Zentiva Secures Acquisition of Five Historic Pharmaceutical Brands
Deal News | Jun 18, 2025 | Finance Community IT - 3 Private Equity
Zentiva, a portfolio company of Advent International, has announced the acquisition of five historic pharmaceutical brands from Aboca, an established Italian company known for its 100% natural pharmaceutical products. Clearwater International acted as the financial advisor in this transaction, with a dedicated team led by managing partner Niccolò Querci. The brands added to Zentiva's catalog are Propol2 EMF, Ruscoven, Serenil, Fisiodepur, and Finocarbo, which fortify Zentiva's position in respiratory care, circulatory system health, and sleep disorder solutions. This acquisition is part of Zentiva's strategy to consolidate its leadership in the Consumer Healthcare sector across Europe, particularly in Italy, Spain, France, as well as expanding into Portugal, Poland, Romania, and Greece. Zentiva operates across 35 countries and serves over 100 million consumers worldwide.
Sectors
- Pharmaceuticals
- Private Equity
Geography
- Europe – Zentiva operates across Europe with the acquisition aimed at strengthening its market position in countries like Italy, Spain, France, and expanding into Portugal, Poland, Romania, and Greece.
- Italy – Aboca, the selling company, is based in Italy, and Zentiva's acquisition includes historic brands from this region.
Industry
- Pharmaceuticals – This industry involves companies producing drugs and therapeutic solutions, as evident from Zentiva's acquisition to expand its catalog with natural products.
- Private Equity – Advent International, a private equity firm, is backing Zentiva, highlighting the industry's role in facilitating strategic expansions through investments.
Financials
- – The specific financial details such as the deal price were not disclosed in the article.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Zentiva | Target Company / Buyer | Company | A pharmaceutical company focusing on high-quality, affordable generic drugs and therapeutic solutions. |
| Advent International | Private Equity Firm | Company | Backing entity of Zentiva, facilitating its strategic acquisitions and expansion. |
| Aboca | Selling Company | Company | An Italian company specializing in 100% natural pharmaceutical products. |
| Clearwater International | Financial Advisor | Company | Advised Zentiva in the acquisition process with a team led by managing partner Niccolò Querci. |